1 reports of this reaction
1.9% of all FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE reports
#18 most reported adverse reaction
GASTRIC CANCER is the #18 most commonly reported adverse reaction for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, manufactured by CVS Pharmacy. There are 1 FDA adverse event reports linking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE to GASTRIC CANCER. This represents approximately 1.9% of all 52 adverse event reports for this drug.
Patients taking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE who experience gastric cancer should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
GASTRIC CANCER is a less commonly reported adverse event for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, but still significant enough to appear in the safety profile.
In addition to gastric cancer, the following adverse reactions have been reported for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE:
The following drugs have also been linked to gastric cancer in FDA adverse event reports:
GASTRIC CANCER has been reported as an adverse event in 1 FDA reports for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
GASTRIC CANCER accounts for approximately 1.9% of all adverse event reports for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, making it a notable side effect.
If you experience gastric cancer while taking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.